Systems biology approaches for toxicology

Journal of Applied Toxicology

Volumn 27, Issue 3, 2007, Pages 201-217

  Slikker Jr , William ^a   Paule, Merle G ^a   Wright, Linnzi K M ^a   Patterson, Tucker A ^a   Wang, Cheng ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Anesthetic agents; ArrayTrack; Development; DNA repair; Gene expression; Neurodegeneration; NMDA receptor antagonist

Indexed keywords

DNA; DNA FRAGMENT; GLUTAMIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KETAMINE; MESSENGER RNA; MITOCHONDRIAL DNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

APOPTOSIS; BIOLOGICAL MODEL; BRAIN DEVELOPMENT; CALCIUM CELL LEVEL; CELL DEATH; CELL STRESS; DNA REPAIR; EXCITOTOXICITY; GEL ELECTROPHORESIS; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VITRO STUDY; IN VIVO STUDY; MICROARRAY ANALYSIS; NERVE CELL; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEOMICS; RECEPTOR BLOCKING; REVIEW; UPREGULATION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; MODELS, BIOLOGICAL; RECEPTORS, N-METHYL-D-ASPARTATE; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; TOXICOLOGY;

MAMMALIA; PRIMATES; RODENTIA;

EID: 34247538105     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1207     Document Type: Review

References (87)

1. Albin R, Makowiec RL, Holligsworth ZR, Dure IVLS, Penny JB, Young AB. 1992. Excitatory amino acid binding sites in the basal ganglia of the rat: quantitative autoradiographic study. Neuroscience 46: 135-148.
2. Auffray C, Imbeaud S, Roux-Rouquie M, Hood L. 2003. From functional genomics to systems biology: concepts and practices. C. R. Biol. 326: 879-892.
3. Bartanusz V, Jezova D, Bertini LT, Tilders FJH, Aubry JM, Kiss JZ. 1993. Stress-induced increase in vasopressin and corticotrophin-releasing factor expression in hypophysiotrophic paraventricular neurons. Endocrinology 132: 895-902.
4. Beal MF. 1992. Mechanisms of excitotoxicity in neurologic diseases. FASEB J. 6: 3338-3344.
5. Behar TN, Scott CA, Greene LC, Wen X, Smith SV, Maric D, Liu Q-Y, Colton CA, Baker IJ. 1999. Glutamate acting at NMDA receptors stimulates embryonic cortical neuronal migration. J. Neurosci. 19: 4449-4461.
6. Choi DW. 1987. Ionic dependence of glutamate neurotoxicity. J. Neurosci. 7: 369-379.
7. Choi DW. 1988. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1: 623-634.
8. Collingridge GL, Kehl SJ, McLennan H. 1983. Excitatory amino acids in synaptic transmission in the Schaffer collateral-commissural pathway of the rat hippocampus. J. Physiol. 334: 33-46.
9. Cotman CW, Geddes JW, Bridges RJ, Monaghan DT. 1989. N-methyl-D-aspartate receptors and Alzheimer's disease. Neurobiol. Aging 10: 603-605.
10. Dignam JD, Lebovitz RM, Roeder RG. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11: 1475-1489.
11. D'Souza SW, McConnell SE, Slater P, Barson AJ. 1993. Glycine site of the excitatory amino acid N-methyl-D-aspartate receptor in neonate and adult brain. Arch. Dis. Child. 69: 212-215.
12. Durand GM, Gregor P, Zheng X, Bennett MV, Uhl GR, Zukin RS. 1992. Cloning of an apparent splice variant of the rat NMDA receptor NMDAR1 with altered sensitivity to polyamines and activators of protein kinase C. Proc. Natl Acad. Sci. USA 89: 9359-9363.
13. Farber NB, Wozniak DF, Price MT, Labruyere J, Huss J, St. Peter H, Olney JW. 1995. Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: potential relevance to schizophrenia? Biol. Psychiatry 38: 783-787.
14. Garthwaite G, Garthwaite J. 1986. Neurotoxicity of excitatory amino acid receptor agonists in rat cerebellar slices: dependence on calcium concentration. Neurosci. Lett. 66: 93-198.
15. Grant KA, Valverius P, Hudspith M, Tabakoff B. 1990. Ethanol withdrawal seizures and the NMDA complex. Eur. J. Pharmacol. 176: 289-296.
16. Graybiel AM. 1990. Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 13: 244-254.
17. Greenamyre JT. 1993. Glutamate-dopamine interactions in the basal ganglia: Relationship to Parkinson's disease. J. Neural Transm. 91: 255-269.
18. Groenewegen HJ, Berendse HW, Meredith GE, Haber SN, Voorn P, Wotters JG, Lohman AHM. 1991. Functional anatomy of the ventral limbic system-innervated striatum. In The Mesolimbic Dopamine System: From Motivation to Action, Willner P, Scheel-Kruger J (eds). John Wiley & Sons: London, 19-59.
19. Groves PM. 1983. A theory of the functional organization of the neostriatum and the neostriatal control of voluntary movement. Brain Res. 286: 109-132.
20. Haberny KA, Paule MG, Scallet AC, Sistare FD, Lester DS, Hanig JP, Slikker W Jr. 2002. Ontogeny of the N-methyl-D-aspartate (NMDA) receptor system and susceptibility of neurotoxicity. Toxicol. Sci. 68: 9-17.
21. Halliwell B. 2001. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 18: 685-716.
22. Hanania T, Hillman GR, Johnson KM. 1999. Augmentation of locomotor activity by chronic phencyclidine is associated with an increase in striatal NMDA receptor function and an upregulation of the NR1 receptor subunit. Synapse 31: 229-239.
23. Henry CJ. 2003. Evolution of toxicology for risk assessment. Int. J. Toxicol. 22: 3-7.
24. Hu X-J, Follesa P, Ticku MK. 1996. Chronic ethanol treatment produces a selective upregulation of the NMDA receptor subunit gene expression in mammalian cultured cortical neurons. Brain Res. Mol. Brain Res. 36: 211-218.
25. Huttenlocher PR. 1979. Synaptic density in human frontal cortex-developmental changes and effects of aging. Brain Res. 163: 195-205.
26. Ikonomidou C, Bosch F, Miksa M, Bittigau P, Vockler J, Dikranian K, Tenkova TI, Stefovska V, Turski L, Olney JW. 1999. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 283: 70-74.
27. Ishii T, Moriyoshi K, Sugihara H, Sakurada K, Kadotani H, Yokoi M, Akazawa C, Shigemoto R, Mizuno N, Masu M, Nakanishi S. 1993. Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits. J. Biol. Chem. 268: 2836-2843.
28. Jazwinski SM. 2002. Biological aging research today: potential, peeves, and problems. Exp. Gerontol. 37: 1141-1146.
29. Jevtovic-Todorovic V, Hartman RE, Izumi Y, Benshoff ND, Dikranian K, Zorumski CF, Olney JW, Wozniak DF. 2003. Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J. Neurosci. 23: 876-882.
30. Johnson KM, Phillips M, Wang C, Kevetter GA. 1998. Chronic phencyclidine induces behavioral sensitization and apoptotic cell death in the olfactory and piriform cortex. J. Neurosci. Res. 52: 709-722.
31. Karp SJ, Masu M, Eki T, Ozawa K, Nakanishi S. 1993. Molecular cloning and chromosomal localization of the key subunit of the human N-methyl-D-aspartate receptor. J. Biol. Chem. 268: 3728-3733.
32. 2+-mediated activation of c-Jun N-terminal kinase and nuclear factor kB by NMDA in cortical cell cultures. J. Neurochem. 71: 1390-1395.
33. Komuro H, Rakic P. 1993. Modulation of neuronal migration by NMDA receptors. Science 260: 95-97.
34. Kotter R. 1994. Postsynaptic integration of glutamatergic and dopaminergic signals in the striatum. Prog. Neurobiol. 44: 163-196.
35. Kumari M, Ticku MK. 1998. Ethanol and regulation of the NMDA receptor subunits in fetal cortical neurons. J. Neurochem. 70: 1467-1473.
36. Kutsuwada T, Kashiwabuchi N, Mori H, Sakimura D, Kushiya E, Araki K, Meguro H, Masaki H, Kumanishi G, Arakawa M, Mishina M. 1992. Molecular diversity of the NMDA receptor channel. Nature 358: 36-41.
37. Lai SK, Wong CK, Yang MS, Yang KK. 2000. Changes in expression of N-methyl-D-aspartate receptor subunits in the rat neostriatum after a single dose of antisense oligonucleotide specific for N-methyl-D-aspartate receptor 1 subunit. Neuroscience 98: 493-500.
38. Laurie DJ, Seeburg PH. 1994. Regional and developmental heterogeneity in splicing of the rat brain NMDAR1 mRNA. J. Neurosci. 14: 3180-3194.
39. Liu A, Hoffman PW, Lu W, Bai G. 2004. NF-kappaB site interacts with Sp factors and up-regulates the NR1 promoter during neuronal differentiation. J. Biol. Chem. 88: 564-575.
40. Lovinger DM, White G, Weight FF. 1989. Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science 243: 1721-1724.
41. Luetjens CM, Bui NT, Sengpiel B, Munstermann G, Poppe M, Krohn AJ, Bauerbach E, Krieglstein, Prehn JH. 2000. Delayed mitochondrial dysfunction in excitotoxic neuron death: cytochrome c release and secondary increase in superoxide production. J. Neurosci. 20: 5715-5723.
42. Malis CD, Bonventre JV. 1985. Mechanism for calcium potentiation of oxygen free radical injury to renal mitochondria. J. Biol. Chem. 261: 14201-14208.
43. McDonald JW, Silverstein FS, Johnston MV. 1990. MK-801 pretreatment enhances N-methyl-D-aspartate brain injury and increases brain N-methyl-D-aspartate recognition site binding in rats. Neuroscience 38: 103-113.
44. McInnis J, Wang C, Anastasio N, Hultman M, Ye Y, Salvemini D, Johnson KM. 2002. The role of superoxide and nuclear factor-kappaB signaling in N-methyl-D-aspartate-induced necrosis and apoptosis. J. Pharmacol. Exp. Ther. 301: 478-487.
45. Meldrum B, Garthwaite J. 1990. Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol. Sci. 11: 379-387.
46. Miyamoto K, Nakanishi H, Moriguchi S, Fukuyama N, Eto K, Wakamiya J, Murao K, Arimura K, Osame M. 2001. Involvement of enhanced sensitivity of N-methyl-D-aspartate receptors in vulnerability of developing cortical neurons to methylmercury neurotoxicity. Brain Res. 901: 252-258.
47. Monyer H, Sprengel R, Schoepfer R, Herb A, Higuchi M, Lomeli H, Burnashev N, Sakmann B, Seeburg PH. 1992. Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256: 1217-1221.
48. Mori H, Mishina M. 1995. Structure and function of the NMDA receptor channel. Neuropharmacology 34: 1219-1237.
49. Moriyoshi K, Masu M, Ishii T, Shigemoto R, Mizuno N, Nakanishi S. 1991. Molecular cloning and characterization of the rat NMDA receptor. Nature 354: 31-37.
50. Muller D, Wang C, Skibo G, Toni N, Cremer H, Calaora V, Rougon G, Kiss JZ. 1996. PSA-NCAM is required for activity-induced synaptic plasticity. Neuron 17: 413-422.
51. Nishi M, Hinds H, Lu HP, Kawata M, Hayashi Y. 2001. Motoneuron-specific expression of NR3B, a novel NMDA-type glutamate receptor subunit that works in a dominant-negative manner. J. Neurosci. 21: RC185.
52. Noble D. 2003. The future: putting Humpty-Dumpty together again. Biochem. Soc. Trans. 31: 156-158.
53. O'Donnell P, Grace AA. 1995. Synaptic interactions among excitatory afferents to nucleus accumbens neurons: hippocampal gating of prefrontal cortical input. J. Neurosci. 15: 3622-3639.
54. Olney JW. 1990. Excitotoxic amino acids and neuropsychiatric disorders. Annu. Rev. Pharmacol. Toxicol. 30: 47-71.
55. Osborn L, Kunkel A, Nabel GJ. 1989. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of nuclear factor kappa B. Proc. Natl Acad. Sci. USA 86: 2336-2340.
56. Patel M, Day BJ, Crapo JD, Fridovich I, McNamara JO. 1996. Requirement for superoxide in excitotoxic cell death. Neuron 16: 345-355.
57. Paule MG. 2001. Validation of a behavioral test battery for monkey. In: Methods of behavioral analysis in neuroscience, Buccafusco JJ (ed). CRC Press LLC: Boca Raton, FL; 281-294.
58. Paupard MC, Friedman LK, Zukin RS. 1997. Developmental regulation and cell-specific expression of NMDA receptor splice variants in rat hippocampus. Neuroscience 79: 399-409.
59. Planells-Cases R, Sun W, Ferrer-Montiel AV, Montal M. 1993. Molecular cloning, functional expression, and pharmacological characterization of an N-methyl-D-aspartate receptor subunit from human brain. Proc. Natl Acad. Sci. USA 90: 5057-5061.
60. Portera-Cailliau C, Price DL, Martin LI. 1997. Non-NMDA and NMDA receptor-mediated excitotoxic neuronal deaths in adult brain are morphologically distinct: Further evidence for an apoptosis-necrosis continuum. J. Comp. Neurol. 378: 88-104.
61. Roberts E, Meredith MA, Ramoa AS. 1998. Suppression of NMDA receptor function using antisense DNA blocks ocular dominance plasticity while preserving visual responses. J. Neurosci. 80: 1021-1032.
62. Rudolf GD, Cronin CA, Landwehrmeyer GB, Standaert DG, Penney JB, Young AB. 1996. Expression of N-methyl-D-aspartate in the prefrontal cortex of the rat. Neuroscience 93: 417-427.
63. Salvemini D, Wang ZQ, Zweier JL, Samouilov A, Macarthur H, Misko TP, Currie MG, Cuzzocrea S, Sikorski JA, Riley DP. 1999. A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats. Science 286: 209-210.
64. Scallet A, Schmued LC, Slikker W, Grunberg N, Faustino PJ, Davis H, Lester D, Pine PS, Sistare F, Hanig JP. 2004. Developmental neurotoxicity of ketamine: morphometric confirmation, exposure parameters, and multiple fluorescent labeling of apoptotic neurons. Toxicol. Sci. 81: 364-370.
65. Shou Y, Gunasekar PG, Borowitz JL, Isom GE. 2000. Cyanide-induced apoptosis involves oxidative-stress-activated NF-kappaB in cortical neurons. Toxicol. Appl. Pharmacol. 164: 196-205.
66. Slikker W, Xu Z, Wang C. 2005. Application of a systems biology approach to developmental neurotoxicology. Reprod. Toxicol. 19: 305-319.
67. Smith AD, Bolam JP. 1990. The neuronal network of the basal ganglia as revealed by the study of synaptic connections of identified neurons. Trends Neurosci. 13: 259-265.
68. Standaert DG, Landwehrmeyer GB, Kerner JA, Penney JBJ, Young AB. 1996. Expression of NMDAR2 glutamate receptor subunit mRNA in neurochemically identified interneurons in the rat neostriatum, neocortex and hippocampus. Brain Res. Mol. Brain Res. 42: 89-102.
69. Sun L, Margolis FL, Shipley MT, Lidow MS. 1998. Identification of a long variant of mRNA encoding the NR3 subunit of the NMDA receptor: its regional distribution and developmental expression in the rat brain. FEBS Lett. 441: 392-396.
70. Toescu EC, Myronova N, Verkhratsky A. 2000. Age-related structural and functional changes of brain mitochondria. Cell Calcium 28: 329-338.
71. Trevisan L, Fitzgerald LW, Brose N, Gasic GP, Heinemann SF, Duman RS, Nestler EJ. 1994. Chronic ingestion of ethanol up-regulates NMDAR1 receptor subunit immunoreactivity in rat hippocampus. J. Neurochem. 62: 1635-1638.
72. Wahlestedt C, Golanov E, Yamamoto S, Yee F, Ericson H, Yoo H, Inturrisi CE, Reis DJ. 1993. Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions. Nature 363: 260-263.
73. Wang C, Anastasio N, Popov V, LeDay A, Johnson KM. 2004. Blockade of N-methyl-D-aspartate receptors by phencyclidine causes the loss of corticostriatal neurons. Neuroscience 125: 473-483.
74. Wang C, Fridley J, Johnson KM. 2005a. The role of NMDA receptor upregulation in phencyclidine-induced cortical apoptosis in organotypic culture. Biochem. Pharmacol. 69: 1373-1383.
75. Wang C, McInnis J, Ross-Sanchez M, Shinnick-Gallagher P, Wiley JL, Johnson KM. 2001. Long-term behavioral and neurodegenerative effects of perinatal phencyclidine administration: implications for schizophrenia. Neuroscience 107: 535-550.
76. Wang C, McInnis J, West JB, Bao J, Anastasio N, Guidry JA, Ye Y, Salvemini D, Johnson KM. 2003. Blockade of phencyclidine-induced cortical apoptosis and deficits in prepulse inhibition by M40403, a superoxide dismutase mimetic. J. Pharmacol. Exp. Ther. 304: 266-271.
77. Wang C, Sadovova N, Fu X, Scallet A, Hanig J, Slikker W. 2005b. The role of NMDA receptors in ketamine-induced apoptosis in rat forebrain culture. Neuroscience 132: 967-977.
78. Wang C, Sadovova N, Hotchkiss C, Fu X, Scallet AC, Patterson TA, Hanig J, Paule MG, Slikker Jr. W. 2006. Blockade of N-methyl-D-aspartate receptors by ketamine produces loss of postnatal day 3 monkey frontal cortical neurons in culture. Toxicol. Sci. 91: 192-201.
79. Wang C, Showalter VM, Jillman GR, Johnson KM. 1999. Chronic phencyclidine increases NMDA receptor NR1 subunit mRNA in rat forebrain. J. Neurosci. Res. 55: 7762-7769.
80. Waters M, Boorman G, Bushel P, Cunningham M, Irwin R, Merrick A, Olden K, Paules R, Selkirk J, Stasiewicz S, Weis B, Van Houten B, Walker N, Tennant R. 2003a. Systems toxicology and the chemical effects in biological systems (CEBS) knowledge base. EHP Toxicogenomics 111: 15-28.
81. Waters MD, Olden K, Tennant RW. 2003b. Toxicogenomic approach for assessing toxicant-related disease. Mutat. Res. 544: 415-424.
82. Williams K, Dichter MA, Molinoff PB. 1992. Up-regulation of N-methyl-D-aspartate receptors on cultured cortical neurons after exposure to antagonists. Mol. Pharmacol. 42: 147-151.
83. Wong HK, Liu XB, Matos MF, Chan SF, Perex-Otano I, Boysen M, Cui J, Nakanishi N, Trimmer JS, Jones EG, Lipton SA, Sucher NJ. 2002. Temporal and regional expression of NMDA receptor subunit NR3A in the mammalian brain. J. Comp. Neurol. 450: 303-317.
84. Wright LKM, Popke EJ, Allen RR, Pearson EC, Hammond TG, Paule MG. 2006. Effect of chronic NMDA receptor and/or sodium channel blockade on learning behavior. Neurotoxicol. Teratol. (submitted).
85. Zahm DS, Brog JS. 1992. On the significance of subterritories in the 'accumbens' part of the rat ventral striatum. Neuroscience 50: 751-767.
86. Zecevic N, Bourgeois JP, Rakic P. 1989. Changes in synaptic density in motor cortex of rhesus monkey during fetal and postnatal life. Brain Res. Dev. Brain Res. 50: 11-32.
87. Zukin RS, Bennett MV. 1995. Alternatively spliced isoforms of the NMDAR1 receptor subunit. Trends Neurosci. 18: 306-313.